Kristin Robin Villalon Harrington, M.D.,Ph.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pharmacies | 4 | 2024 | 164 | 1.180 |
Why?
|
Pharmaceutical Services | 1 | 2023 | 141 | 0.780 |
Why?
|
Pharmacy | 1 | 2023 | 92 | 0.770 |
Why?
|
Contact Tracing | 1 | 2022 | 268 | 0.690 |
Why?
|
Vasculitis, Central Nervous System | 1 | 2019 | 45 | 0.630 |
Why?
|
Chickenpox | 1 | 2019 | 97 | 0.610 |
Why?
|
Tuberculosis, Multidrug-Resistant | 2 | 2024 | 930 | 0.600 |
Why?
|
HIV Infections | 7 | 2024 | 17165 | 0.500 |
Why?
|
Lung Diseases | 1 | 2021 | 1915 | 0.370 |
Why?
|
Georgia | 2 | 2024 | 190 | 0.260 |
Why?
|
Heroin Dependence | 1 | 2023 | 172 | 0.200 |
Why?
|
Quarantine | 1 | 2024 | 176 | 0.200 |
Why?
|
Respiratory Function Tests | 1 | 2024 | 1683 | 0.170 |
Why?
|
Pulmonary Emphysema | 1 | 2024 | 688 | 0.160 |
Why?
|
South Africa | 1 | 2024 | 1821 | 0.160 |
Why?
|
Communicable Disease Control | 1 | 2024 | 844 | 0.150 |
Why?
|
Sexually Transmitted Diseases | 1 | 2023 | 628 | 0.140 |
Why?
|
Universities | 1 | 2022 | 992 | 0.140 |
Why?
|
Bayes Theorem | 1 | 2024 | 2326 | 0.130 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2015 | 85 | 0.120 |
Why?
|
Disease Outbreaks | 1 | 2022 | 1758 | 0.110 |
Why?
|
Students | 1 | 2022 | 1730 | 0.100 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2016 | 586 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3164 | 0.090 |
Why?
|
Intensive Care Units | 1 | 2022 | 3736 | 0.080 |
Why?
|
Opioid-Related Disorders | 1 | 2023 | 2138 | 0.080 |
Why?
|
Hospital Mortality | 1 | 2022 | 5425 | 0.070 |
Why?
|
Antitubercular Agents | 1 | 2016 | 1373 | 0.070 |
Why?
|
Pandemics | 2 | 2024 | 8624 | 0.070 |
Why?
|
Humans | 16 | 2024 | 760621 | 0.070 |
Why?
|
Fatty Acids | 1 | 2015 | 1804 | 0.070 |
Why?
|
Male | 11 | 2024 | 359744 | 0.070 |
Why?
|
Young Adult | 4 | 2024 | 58741 | 0.060 |
Why?
|
Hospitals | 1 | 2019 | 3928 | 0.060 |
Why?
|
Homosexuality, Male | 2 | 2023 | 1273 | 0.060 |
Why?
|
Mycobacterium tuberculosis | 1 | 2016 | 1903 | 0.060 |
Why?
|
Primary Health Care | 1 | 2021 | 4647 | 0.060 |
Why?
|
Smoking | 1 | 2021 | 9073 | 0.060 |
Why?
|
Middle Aged | 6 | 2024 | 220352 | 0.060 |
Why?
|
Adult | 6 | 2024 | 219994 | 0.050 |
Why?
|
Prospective Studies | 2 | 2024 | 54303 | 0.050 |
Why?
|
Nucleocapsid | 1 | 2022 | 63 | 0.050 |
Why?
|
Heroin | 1 | 2023 | 119 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 25942 | 0.050 |
Why?
|
Hospitalization | 1 | 2022 | 10790 | 0.050 |
Why?
|
Vital Capacity | 1 | 2024 | 965 | 0.050 |
Why?
|
Cohort Studies | 2 | 2022 | 41335 | 0.050 |
Why?
|
United States | 3 | 2024 | 72461 | 0.040 |
Why?
|
Forced Expiratory Volume | 1 | 2024 | 1809 | 0.040 |
Why?
|
Adolescent | 2 | 2024 | 87810 | 0.040 |
Why?
|
Female | 7 | 2024 | 391270 | 0.030 |
Why?
|
Philippines | 1 | 2016 | 91 | 0.030 |
Why?
|
Educational Status | 1 | 2022 | 2515 | 0.030 |
Why?
|
Lipogenesis | 1 | 2015 | 210 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2022 | 2062 | 0.030 |
Why?
|
Adipose Tissue, White | 1 | 2015 | 365 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 36290 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2022 | 2754 | 0.020 |
Why?
|
Poverty | 1 | 2022 | 2695 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3143 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2016 | 1949 | 0.020 |
Why?
|
Critical Illness | 1 | 2022 | 2709 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2015 | 2222 | 0.020 |
Why?
|
Mass Screening | 1 | 2024 | 5423 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2022 | 80372 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2022 | 14660 | 0.020 |
Why?
|
Triglycerides | 1 | 2015 | 2476 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2023 | 3763 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14495 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2015 | 1902 | 0.020 |
Why?
|
Lung | 1 | 2024 | 9994 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6498 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2015 | 3301 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2024 | 20509 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 8035 | 0.010 |
Why?
|
Time Factors | 1 | 2022 | 40165 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2015 | 14372 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2015 | 22023 | 0.010 |
Why?
|
Child | 1 | 2022 | 79806 | 0.010 |
Why?
|
Aged | 1 | 2022 | 169152 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2016 | 65017 | 0.010 |
Why?
|
Risk Factors | 1 | 2016 | 74359 | 0.000 |
Why?
|
Mice | 1 | 2015 | 81208 | 0.000 |
Why?
|
Animals | 1 | 2015 | 167963 | 0.000 |
Why?
|